CHIPSCREEN BIOSCIENCES was established in March 2001, and is currently a leading enterprise of small molecule innovative medicines in China.
CHIPSCREEN BIOSCIENCES puts as the first priority to meet unmet clinical needs. It insists on an “original, safe, excellent and effective China,” and is dedicated in providing patients with affordable innovative mechanisms of therapeutic drugs. ”
CHIPSCREEN BIOSCIENCES owns headquarters, research and development centers, and GMP production bases in Shenzhen and Chengdu, as well as the Beijing clinical research center and Shanghai commercial center, which is a four-in-one modern biomedicine group company.
Chipscreen Biosciences's Original New Drug CS12192: Investigational New Drug (IND) Application Accepted
Master Class of SSE about Science & Technology Innovation: Development and Opportunities of Chinese Innovative Drugs